OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR STROKE AND DEATH 7.ParbixA BechichaTime Cooper ES,Dyken ML,Eastone D.National 33.Beelke M,Angeli S,Del Sette M,et al EW. G.Miller M.Au usban yI Skat positive o.Lancet 1985:2:1 0.p 23.B tal i 1972-4 cd1992:83:555 ciati 5.a arrizo SJ,Vincente E.Agust 3.Haya serva isord ng and car s:a et120022015118 sleep-related breathing disc cthity in the and dev t of 40.YokoeT.M the -5531 19992 p apnea sy 02003107a 120.34 1.Netz r B.Jochums 1,Leh M,PL tructive hy- LM,Ber 50kc19829-879 in sle 00311076-0 ENTATIONS AT MEDICAL MEETINGS ON THE INTERNE osting an audio sofanoalpies on at a medical meeting on th s trom the p entation,will not be c ed prid the slides.if there a bo gshoaldfaaeoealhejunursEdieioice N ENGLJ MED 353:19 WWW.NEJM.ORG NOVEMBER 10,2005 2041 Downloaded from www.nejm.orgonJanuary 23.010.Massachusetts Medical Socety.All rights reserved n engl j med 353;19 www.nejm.org november 10, 2005 obstructive sleep apnea as a risk factor for stroke and death 2041 7. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic at￾tack. Am J Respir Crit Care Med 2000;161: 375-80. 8. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep￾disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5. 9. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985;2:1325-6. 10. Palomaki H. Snoring and the risk of is￾chemic brain infarction. Stroke 1991;22: 1021-5. 11. Spriggs DA, French JM, Murdy JM, Cur￾less RH, Bates D, James OF. Snoring in￾creases the risk of stroke and adversely af￾fects prognosis. Q J Med 1992;83:555-62. 12. Smirne S, Palazzi S, Zucconi M, Chierchia S, Ferini-Strambi L. Habitual snor￾ing as a risk factor for acute vascular disease. Eur Respir J 1993;6:1357-61. 13. Neau JP, Meurice JC, Paquereau J, Chav￾agnat JJ, Ingrand P, Gil R. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand 1995;92:63-8. 14. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovas￾cular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. 15. Johns MW. Daytime sleepiness, snor￾ing, and obstructive sleep apnea: the Ep￾worth Sleepiness Scale. Chest 1993;103: 30-6. 16. Sleep-related breathing disorders in adults: recommendations for syndrome def￾inition and measurement techniques in clinical research: the Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89. 17. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Informa￾tion Service/Brain Research Institute, 1968. 18. Meoli AL, Casey KR, Clark RW, et al. Hy￾popnea in sleep-disordered breathing in adults. Sleep 2001;24:469-70. 19. Meschia JF, Brott TG, Chukwudelunzu FE, et al. Verifying the stroke-free phenotype by structured telephone interview. Stroke 2000;31:1076-80. 20. Whisnant JD, Busford JR, Bernstein EF, Cooper ES, Dyken ML, Eastone D. National Institute of Neurological Disorders and Stroke special report: classification of cere￾brovascular disease. Stroke 1990;21:637-76. 21. Schisterman EF, Whitcomb BW. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2004;2:2-6. 22. Social Security Death Index. (Accessed October 17, 2005, at http://www.ancestry. com/search/rectype/vital/ssdi/main.htm.) 23. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and to￾tal incidence rates of stroke among blacks. Stroke 1998;29:415-21. 24. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hyperten￾sion. N Engl J Med 2000;342:1378-84. 25. Marin JM, Carrizo SJ, Vincente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypop￾noea with or without treatment with contin￾uous positive airway pressure: an observa￾tional study. Lancet 2005;365:1046-53. 26. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analy￾sis of risk factors. Sleep 1995;18:149-57. 27. Marti S, Sampol G, Munoz X, et al. Mor￾tality in severe sleep apnoea/hypopnoea syn￾drome patients: impact of treatment. Eur Respir J 2002;20:1511-8. 28. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep ap￾noea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 1988;6:S529-S531. 29. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147-65. 30. Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest 1989;95:279-83. 31. Netzer N, Werner P, Jochums I, Leh￾mann M, Strohl KP. Blood flow of the mid￾dle cerebral artery with sleep-disordered breathing: correlation with obstructive hy￾popneas. Stroke 1998;29:87-93. 32. Franklin KA. Cerebral hemodynamics in obstructive sleep apnoea and Cheyne￾Stokes respiration. Sleep Med Rev 2002;6: 429-41. 33. Beelke M, Angeli S, Del Sette M, et al. Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep 2002;25:856-62. 34. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a pre￾liminary investigation. Chest 1995;108:625- 30. 35. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in ob￾structive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153:1972-6. 36. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium￾dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Cir￾culation 2000;102:2607-10. 37. Hayashi M, Fujimoto K, Urushibata K, Uchikawa S, Imamura H, Kubo K. Noctur￾nal oxygen desaturation correlates with the severity of coronary atherosclerosis in cor￾onary artery disease. Chest 2003;124:936- 41. 38. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in pa￾tients with obstructive sleep apnea. Circula￾tion 2003;107:68-73. 39. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeu￾tic nasal continuous positive airway pres￾sure for obstructive sleep apnoea: a random￾ised parallel trial. Lancet 2002;359:204-10. 40. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and in￾terleukin-6 in patients with obstructive sleep apnea syndrome are decreased by na￾sal continuous positive airway pressure. Cir￾culation 2003;107:1129-34. 41. Somers VK, Dyken ME, Clary MP, Ab￾boud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904. 42. Diomedi M, Placidi F, Cupini LM, Ber￾nardi G, Silvestrini M. Cerebral hemody￾namic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology 1998;51: 1051-6. Copyright © 2005 Massachusetts Medical Society. posting presentations at medical meetings on the internet Posting an audio recording of an oral presentation at a medical meeting on the Internet, with selected slides from the presentation, will not be considered prior publication. This will allow students and physicians who are unable to attend the meeting to hear the presentation and view the slides. If there are any questions about this policy, authors should feel free to call the Journal’s Editorial Offices. Downloaded from www.nejm.org on January 23, 2010 . Copyright © 2005 Massachusetts Medical Society. All rights reserved